COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,241 Articles (22,733 medRxiv, 8,508 bioRxiv)

Most recent first Previous |  Page 1917: Articles 19161-19170  | Next

Genomic epidemiology of the SARS-CoV-2 epidemic in Zimbabwe: Role of international travel and regional migration in spread
Mashe, T., Takawira, F. T., Martins, L. d. O., Gudza-Mugabe, M., Chirenda, J., Munyanyi, M., Gumbo, H., Chaibva, B. V., Nyagupe, C., Tarupiwa, A., Juru, A., Phiri, I., Manangazira, P., Goredema, A., Danda, S., Chabata, I., Jonga, J., Munharira, R., Masunda, K., Mukeredzi, I., Mangwanya, D., The COVID-19 Genomics UK (COG-UK) Consortium, , SARS-CoV-2 Research Group, , Trotter, A., Le Viet, T., Kay, G., Baker, D., Thilliez, G., Gutierrez, A.-V., O Grady, J., Hove, M., Mutapuri-Zinyowera, S., Page, A. J., Kingsley, R. A., Mhlanga, G.
10.1101/2021.01.04.20232520 — Posted: 2021-01-06
Machine Learning Forecast of Growth in COVID-19 Confirmed Infection Cases with Non-Pharmaceutical Interventions and Cultural Dimensions: Algorithm Development and Validation
Yeung, A. Y., Roewer-Despres, F., Rosella, L., Rudzicz, F.
10.1101/2021.01.04.21249235 — Posted: 2021-01-06
SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals
Coyle, P. V., Chemaitelly, H., Kacem, M. A. B. H., Al Molawi, N. H. A., El Kahlout, R. A., Gilliani, I., Younes, N., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Butt, A. A., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Nasrallah, G. K., Yassine, H. M., Al Kuwari, M. G., Al Romaihi, H. E., Al-Thani, M. H., Bertollini, R., Abu-Raddad, L. J.
10.1101/2021.01.05.21249247 — Posted: 2021-01-06
Associations between Stress and Child Verbal Abuse and Corporal Punishment during the COVID-19 Pandemic and Potential Effect Modification by Lockdown Measures
Jeharsae, R., Jae-noh, M., Jae-a-lee, H., Waeteh, S., Nimu, N., Chewae, C., Yama, M., Dureh, N., Wichaidit, W.
10.1101/2021.01.05.20248973 — Posted: 2021-01-06
Viral Variants and Vaccinations: If We Can Change the COVID-19 Vaccine, Should We?
Bewick, S.
10.1101/2021.01.05.21249255 — Posted: 2021-01-06
Prevalence of RT-PCR-detected SARS-CoV-2 infection at schools: First results from the Austrian School-SARS-CoV-2 Study
Willeit, P., Krause, R., Lamprecht, B., Berghold, A., Hanson, B., Stelzl, E., Stoiber, H., Zuber, J., Heinen, R., Koehler, A., Bernhard, D., Borena, W., Doppler, C., von Laer, D., Schmidt, H., Proell, J., Steinmetz, I., Wagner, M.
10.1101/2021.01.05.20248952 — Posted: 2021-01-06 Discussion: Onsite
Representative Estimates of COVID-19 Infection Fatality Rates from Three Locations in India
Cai, R., Novosad, P., Tandel, V., Asher, S., Malani, A.
10.1101/2021.01.05.21249264 — Posted: 2021-01-06
Stochastic model for COVID-19 in slums: interaction between biology and public policies
Solari, H. G., Natiello, M. A.
10.1101/2021.01.06.21249318 — Posted: 2021-01-06
A novel computational approach to reconstruct SARS-CoV-2 infection dynamics through the inference of unsampled sources of infection
Perera, D., Perks, B., Potemkin, M., Gordon, P., Gill, J., van Marle, G., Long, Q.
10.1101/2021.01.04.21249233 — Posted: 2021-01-06 Discussion: Onsite
Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing or Completed Randomized Trials
H. Talasaz, A., Sadeghipour, P., Kakavand, H., Aghakouchakzadeh, M., Van Tassell, B. W., Kordzadeh-Kermani, E., Gheymati, A., Ariannrjad, H., Hosseini, S. H., Jamalkhani, S., Sholzberg, M., Monreal, M., Jimenez, D., Piazza, G., Parikh, S. A., Kirtane, A. J., Eikelboom, J. W., Connors, J. M., Hunt, B. J., Konstantinides, S. V., Cushman, M., Weitz, J. I., Stone, G., Krumholz, H., Lip, G. Y. H., Goldhaber, S. Z., Bikdeli, B.
10.1101/2021.01.04.21249227 — Posted: 2021-01-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).